Human IFN-Alpha in Healthy Donor and Influenza Patient Sera measured by VeriKine-HS Human IFN-Alpha All-Subtype ELISA (41115-1).
Levels of Human IFN-Beta in 128 Healthy Donors and 54 Multiple Sclerosis (MS) Sera on and off IFN-Beta therapies; measured by VeriKine-HS Human IFN-Beta ELISA (41415-1)
Endogenous Human IFN-Alpha level in Sendai Virus infected A549 Cells measured by VeriKine-HS Human IFN-Alpha TCM ELISA (41135-1)
Parallelism of Disease Serum: Four Atopic Dermatitis (AD) sera with high endogenous Human IL-22 levels were assayed on VeriKine-HS Human IL-22 ELISA (41701-1)
Detection of Human IL-15/IL-15Ra Complex in Healthy Donor Serum (HDS), Sample Diluent (SD), and Tissue Culture Media (TCM) (41702-1)
PBL Assay Science designs our VeriKine-HS (High Sensitivity) ELISA kits with a singular purpose: to provide researchers like you with the tools that enable the generation of accurate, reproducibile, and actionable data you can trust. Our VeriKine-HS kits feature:
- Accurate sample measurement with total IFN-Alpha subtype detection at low pg/ml levels.
- Robust matrix tolerance and reproducibility with healthy and disease patient sera such as autoimmune and infection diseases.
- Near-basal endogenous Human IL-15 and IL-22 quantitation.
VeriKine-HS Human IFN ELISA Kits
Speak to Our Scientist